This webinar will provide an overview of the evolution of prescribing information (PI) format and content, key regulations impacting drug interaction (DI) content in the PI, and the regulatory science behind, including essential DI information in the PI. In addition, alternative display methods to enhance readability and utility as well as unique DI related content (e.g., in vitro information, modeling and simulation, and complex DI scenarios) will also be discussed.